Community-Based Aerosol Transmission Of COVID-19 and HVAC Systems
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, spreads when an infected person breathes out, sneezes, coughs, or talks, thus putting virus-carrying liquid particles into the air where they can infect other people. Larger particles fall to the ground rapidly, while smaller particles, sometimes called aerosols, can linger in the air. Some infectious diseases — such as measles, tuberculosis, and influenza — are known to spread through heating, ventilation, and air conditioning (HVAC) systems, raising concern that the same may be true of COVID-19. In this webinar, a panel of experts will outline what is known about how COVID-19 is transmitted and discuss what the latest research shows about the potential role HVAC systems play in spreading or mitigating the risk of transmitting COVID-19.
Speakers:
Mr. K. William (Bill) Dean, Vice-President, ASHRAE, Inc.
Dr. David Fisman, Professor, Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto
Dr. Jason Kindrachuk, Assistant Professor, Department of Medical Microbiology and Infectious Diseases, University of Manitoba
Heather Logan, Executive Strategy Lead, CADTH (moderator)
Видео Community-Based Aerosol Transmission Of COVID-19 and HVAC Systems канала Canada’s Drug Agency
Speakers:
Mr. K. William (Bill) Dean, Vice-President, ASHRAE, Inc.
Dr. David Fisman, Professor, Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto
Dr. Jason Kindrachuk, Assistant Professor, Department of Medical Microbiology and Infectious Diseases, University of Manitoba
Heather Logan, Executive Strategy Lead, CADTH (moderator)
Видео Community-Based Aerosol Transmission Of COVID-19 and HVAC Systems канала Canada’s Drug Agency
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
There's Always Evidence (Part 2) - Beyond RCTs: The Many Benefits of Observational StudiesCADTH in Conversation with…. Professor Gillian Leng CBE, Chief Executive of NICEINFORMATION SESSION — Introducing CADTH’s New Post-Market Drug Evaluation Program2017 CADTH Symposium: Janet Knox2017 CADTH Symposium: Robyn LimCADTH Drug Reimbursement ReviewsHow CADTH Expert Committees Deliberate2017 CADTH Symposium: Ken MilneRelease of the CADTH Health Economic GuidelinesRecommendation Mapping: A New Approach to Digitizing and Presenting Living GuidelinesThere's Always Evidence Part 3 - Observational Studies: A Deeper DiveDr. Wendy Ungar, Recipient of the 2020 Dr. Jill M. Sanders Award of Excellence in HTAImpact of Zika Virus-Associated Neurological Disorders on Health-Related Quality of Life2018 CADTH Symposium — Oral Presentations: Opioids2018 CADTH Symposium: Dr. Tony Fields, the 2018 Dr. Jill M. Sanders Award RecipientImplementing Health Technology–Related DecisionsToward Standardized Structured Reporting for the Management of Multiple Myeloma in AlbertaThere’s Always Evidence: Part 1COVID-19 and the Surge in Virtual Care: Lessons Learned and Challenges to ComeNon-Pharmacological Interventions for Chronic Non-Cancer Pain: Acupuncture